Zobrazeno 1 - 10
of 358
pro vyhledávání: '"H.T. Mouridsen"'
Publikováno v:
European journal of cancer (Oxford, England : 1990). 39(7)
Two immunoassays for quantitation of the biological markers uPA and PAI-1 were evaluated for their use with detergent extracts of breast cancer tissue. Both assays were based on murine monoclonal capture antibodies and rabbit polyclonal detector anti
Autor:
Carsten Rose, B. Kristensen, Jens O. Andersen, Bent Ejlertsen, H.T. Mouridsen, Inger Højris, K Møholt, Steinbjørn Hansen, Mogens Kjaer
Publikováno v:
Ejlertsen, B, Højris, I, Hansen, S, Møholt, K, Kristensen, B, Mouridsen, H T, Andersen, J, Rose, C & Kjær, M 2003, ' Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group ', Breast, vol. 12, no. 1, pp. 42-50 . https://doi.org/10.1016/S0960-9776(02)00180-7
Ejlertsen, B, Hojris, I, Hansen, S, Moholt, K, Kristensen, B, Mouridsen, H T, Andersen, J, Rose, C & Kjaer, M 2003, ' Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer : a pilot study performed by the Danish Breast Cancer Cooperative Group ', Breast, vol. 12, no. 1, pp. 42-50 . https://doi.org/10.1016/S0960-9776(02)00180-7
Ejlertsen, B, Hojris, I, Hansen, S, Moholt, K, Kristensen, B, Mouridsen, H T, Andersen, J, Rose, C & Kjaer, M 2003, ' Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer : a pilot study performed by the Danish Breast Cancer Cooperative Group ', Breast, vol. 12, no. 1, pp. 42-50 . https://doi.org/10.1016/S0960-9776(02)00180-7
This pilot study investigated the tolerability and efficacy of increasing doses of epirubicin and vinorelbine as first-line chemotherapy for metastatic breast cancer. Acute toxicity was manageable at all dose levels for combinations of epirubicin 60-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e388a6862b63a433396191c95b1fb84c
https://pure.au.dk/portal/da/publications/combined-epirubicin-and-vinorelbine-as-firstline-therapy-in-metastatic-breast-cancer-a-pilot-study-performed-by-the-danish-breast-cancer-cooperative-group(12538240-9561-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/combined-epirubicin-and-vinorelbine-as-firstline-therapy-in-metastatic-breast-cancer-a-pilot-study-performed-by-the-danish-breast-cancer-cooperative-group(12538240-9561-11da-bee9-02004c4f4f50).html
Autor:
Anita Niebuhr, Kirsten Fenger, R.B. Barkardottir, B. Ejlertsen, Åke Borg, J.H. Olsen, H.T. Mouridsen, Erik Niebuhr, K.V. Nielsen, S. Klausen, K. Winther, Theresa Larriba Harboe, Jon Thor Bergthorsson
Publikováno v:
Journal of medical genetics. 38(6)
INTRODUCTIONA small fraction of breast cancer is the result of germline mutations in theBRCA1 and BRCA2cancer susceptibility genes. Mutation carriers frequently have a positive family history of breast and ovarian cancer, are often diagnosed at a you
Autor:
H.A. Chaudri-Ross, H.T. Mouridsen
Publikováno v:
European Journal of Cancer. 40:1095-1096
Autor:
H.T. Mouridsen
Publikováno v:
European Journal of Cancer Supplements. 1:263-264
Autor:
H.T. Mouridsen, Peer Christiansen, Anne Vibeke Lænkholm, BV Offersen, Maj-Britt Jensen, Bent Ejlertsen, Karsten Bjerre, M.E. Kvistgaard, Birgitte Bruun Rasmussen, S. Møller, D.B. Toftdahl, Niels Kroman
Publikováno v:
The Breast. 20:S14
Autor:
H.T. Mouridsen
Publikováno v:
European journal of cancer (Oxford, England : 1990). (4)
Systemic adjuvant therapy has improved the prognosis of patients with primary breast cancer. Meta-analyses have demonstrated that approximately one fourth of deaths can be avoided among younger women treated with multiple cytotoxic drug regimens and
Publikováno v:
The Breast. 4:245-246
Autor:
H.T. Mouridsen
Publikováno v:
European Journal of Cancer. 31:826-827
Autor:
H.T. Mouridsen, T. Palshof
Publikováno v:
European Journal of Cancer Supplements. 1:S123